iBio (IBIO) Common Equity (2016 - 2025)
Historic Common Equity for iBio (IBIO) over the last 16 years, with Q4 2025 value amounting to $56.6 million.
- iBio's Common Equity rose 30705.29% to $56.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $56.6 million, marking a year-over-year increase of 30705.29%. This contributed to the annual value of $14.9 million for FY2025, which is 3021.95% down from last year.
- According to the latest figures from Q4 2025, iBio's Common Equity is $56.6 million, which was up 30705.29% from $56.0 million recorded in Q3 2025.
- In the past 5 years, iBio's Common Equity registered a high of $108.6 million during Q2 2021, and its lowest value of $9.2 million during Q4 2023.
- Its 5-year average for Common Equity is $44.3 million, with a median of $23.1 million in 2024.
- Its Common Equity has fluctuated over the past 5 years, first surged by 254922.92% in 2021, then tumbled by 7922.36% in 2022.
- Quarter analysis of 5 years shows iBio's Common Equity stood at $90.6 million in 2021, then crashed by 79.22% to $18.8 million in 2022, then crashed by 51.14% to $9.2 million in 2023, then soared by 51.08% to $13.9 million in 2024, then surged by 307.05% to $56.6 million in 2025.
- Its Common Equity stands at $56.6 million for Q4 2025, versus $56.0 million for Q3 2025 and $14.9 million for Q2 2025.